Hemorrhagic Fever, Ebola

6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Infections, Virus Diseases

Treatments and conditions

Hemorrhagic Fever, Ebola
Treatment and conditionWhere it standsTrials
Ad26.ZEBOV + MVA-BN-Filo for hemorrhagic fever, ebolaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ansuvimab for hemorrhagic fever, ebolaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ervebo® booster for hemorrhagic fever, ebolaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Inmazeb for hemorrhagic fever, ebolaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RECOMBINANT ZAIRE EBOLAVIRUS KIKWIT-95 ENVELOPE GLYCOPROTEIN MODIFIED VESICULAR STOMATITIS VIRUS for hemorrhagic fever, ebolaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zabdeno® booster for hemorrhagic fever, ebolaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.